Shedding of a soluble form of BMP receptor-IB controls bone cell responses to BMP

Bone

Volumn 39, Issue 5, 2006, Pages 1008-1017

  Singhatanadgit, W ^a   Salih, V ^a   Olsen, I ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Bone cells; Bone morphogenetic protein; Bone morphogenetic protein receptor; Shedding; Soluble receptor

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; INTERLEUKIN 1BETA; MESSENGER RNA; OSTEOCALCIN; PHORBOL 12 ACETATE 13 MYRISTATE; SMAD1 PROTEIN; SMAD5 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BONE CELL; CELL DIFFERENTIATION; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SUPERNATANT;

BLOTTING, WESTERN; BONE AND BONES; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; INTERLEUKIN-1BETA; OSTEOBLASTS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMAD1 PROTEIN; SMAD5 PROTEIN; SOLUBILITY; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 33749532652     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.04.030     Document Type: Article

References (62)

1. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., et al. Novel regulators of bone formation: molecular clones and activities. Science 242 (1988) 1528-1534
2. Mehler M.F., Mabie P.C., Zhang D., and Kessler J.A. Bone morphogenetic proteins in the nervous system. Trends Neurosci 20 (1997) 309-317
3. Reddi A.H. Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev 8 (1997) 11-20
4. Reddi A.H. Bone morphogenetic proteins and skeletal development: the kidney-bone connection. Pediatr Nephrol 14 (2000) 598-601
5. Nakashima M., and Reddi A.H. The application of bone morphogenetic proteins to dental tissue engineering. Nat Biotechnol 21 (2003) 1025-1032
6. Dale L., and Jones C.M. BMP signalling in early Xenopus development. Bioessays 21 (1999) 751-760
7. Schilephake H. Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 31 (2002) 469-484
8. Bessho K., Carnes D.L., Cavin R., Chen H.Y., and Ong J.L. BMP stimulation of bone response adjacent to titanium implants in vivo. Clin Oral Implants Res 10 (1999) 212-218
9. Cochran D.L., Jones A.A., Lilly L.C., Fiorellini J.P., and Howell H. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol 71 (2000) 1241-1257
10. Osyczka A.M., Diefenderfer D.L., Bhargave G., and Leboy P.S. Different effects of BMP-2 on marrow stromal cells from human and rat bone. Cells Tissues Organs 176 (2004) 109-119
11. Cheng H., Jiang W., Phillips F.M., Haydon R.C., Peng Y., Zhou L., et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Jt Surg Am 85-A (2003) 1544-1552
12. Park J., Ries J., Gelse K., Kloss F., von der M.K., Wiltfang J., et al. Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Gene Ther 10 (2003) 1089-1098
13. Nohe A., Keating E., Knaus P., and Petersen N.O. Signal transduction of bone morphogenetic protein receptors. Cell Signal 16 (2004) 291-299
14. ten Dijke P., Yamashita H., Sampath T.K., Reddi A.H., Estevez M., Riddle D.L., et al. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 269 (1994) 16985-16988
15. Nohno T., Ishikawa T., Saito T., Hosokawa K., Noji S., Wolsing D.H., et al. Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J Biol Chem 270 (1995) 22522-22526
16. Liu F., Ventura F., Doody J., and Massague J. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol 15 (1995) 3479-3486
17. Yamashita H., ten Dijke P., Heldin C.H., and Miyazono K. Bone morphogenetic protein receptors. Bone 19 (1996) 569-574
18. ten Dijke P., Fu J., Schaap P., and Roelen B.A.J. Signal transduction of bone morphogenetic proteins in osteoblast differentiation. J Bone Jt Surg 85 (2003) 34-38
19. Hayes S., Chawla A., and Corvera S. TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2. J Cell Biol 158 (2002) 1239-1249
20. Di Guglielmo G.M., Le C., Roy A.F., and Goodfellow J.L. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 5 (2003) 410-421
21. Anders R.A., Arline S.L., Dore J.J., and Leof E.B. Distinct endocytic responses of heteromeric and homomeric transforming growth factor beta receptors. Mol Biol Cell 8 (1997) 2133-2143
22. Dore Jr. J.J., Yao D., Edens M., Garamszegi N., Sholl E.L., and Leof E.B. Mechanisms of transforming growth factor-beta receptor endocytosis and intracellular sorting differ between fibroblasts and epithelial cells. Mol Biol Cell 12 (2001) 675-684
23. Jortikka L., Laitinen M., Lindholm T.S., and Marttinen A. Internalization and intracellular processing of bone morphogenetic protein (BMP) in rat skeletal muscle myoblasts (L6). Cell Signal 9 (1997) 47-51
24. Oates T.W., Xie J.F., Clinton S., Hoang A.M., Graves D.T., and Cochran D.L. PDGF-alpha receptor subunit expression down-regulated by IL-1beta in human periodontal ligament cells. J Dent Res 77 (1998) 1791-1798
25. Lum L., Wong B.R., Josien R., Becherer J.D., Erdjument-Bromage H., Schlondorff J., et al. Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem 274 (1999) 13613-13618
26. Philip A., Hannah R., and O'connor-McCourt M. Ectodomain cleavage and shedding of the type III transforming growth factor-beta receptor in lung membranes effect of temperature, ligand binding and membrane solubilization. Eur J Biochem 261 (1999) 618-628
27. Yabkowitz R., Meyer S., Black T., Elliott G., Merewether L.A., and Yamane H.K. Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation. Blood 93 (1999) 1969-1979
28. Hanneken A. Structural characterization of the circulating soluble FGF receptors reveals multiple isoforms generated by secretion and ectodomain shedding. FEBS Lett 489 (2001) 176-181
29. Garton K.J., Gough P.J., Philalay J., Wille P.T., Blobel C.P., Whitehead R.H., et al. Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). J Biol Chem 278 (2003) 37459-37464
30. Hu Q., Dey A.L., Yang Y., Shen Y., Jilani I.B., Estey E.H., et al. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes. Cancer 100 (2004) 1884-1891
31. Sahin U., Weskamp G., Kelly K., Zhou H.M., Higashiyama S., Peschon J., et al. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 164 (2004) 769-779
32. Dello S.P., and Rovida E. Transmodulation of cell surface regulatory molecules via ectodomain shedding. Biol Chem 383 (2002) 69-83
33. Kotake S., Sato K., Kim K.J., Takahashi N., Udagawa N., Nakamura I., et al. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res 11 (1996) 88-95
34. Jones S.A., Horiuchi S., Topley N., Yamamoto N., and Fuller G.M. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 15 (2001) 43-58
35. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385 (1997) 729-733
36. Pinckard J.K., Sheehan K.C., Arthur C.D., and Schreiber R.D. Constitutive shedding of both p55 and p75 murine TNF receptors in vivo. J Immunol 158 (1997) 3869-3873
37. Vermes C., Jacobs J.J., Zhang J., Firneisz G., Roebuck K.A., and Glant T.T. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts. J Biol Chem 277 (2002) 16879-16887
38. Tanida S., Joh T., Itoh K., Kataoka H., Sasaki M., Ohara H., et al. The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells. Gastroenterology 127 (2004) 559-569
39. Franchimont N., Lambert C., Huynen P., Ribbens C., Relic B., Chariot A., et al. Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells. Arthritis Rheum 52 (2005) 84-93
40. Spinella-Jaegle S., Roman-Roman S., Faucheu C., Dunn F.W., Kawai S., Gallea S., et al. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on osteoblast differentiation. Bone 29 (2001) 323-330
41. Doglioli P., and Scortecci G. Characterization of endosteal osteoblasts isolated from human maxilla and mandible: an experimental system for biocompatibility tests. Cytotechnology 7 (1991) 39-48
42. Pradel W., Tenbieg P., and Lauer G. Influence of harvesting technique and donor site location on in vitro growth of osteoblastlike cells from facial bone. Int J Oral Maxillofac Implants 20 (2005) 860-866
43. Salih V., Knowles J.C., O'Hare M.J., and Olsen I. Retroviral transduction of alveolar bone cells with a temperature-sensitive SV40 large T antigen. Cell Tissue Res 304 (2001) 371-376
44. Kuru L., Parkar M.H., Griffiths G.S., and Olsen I. Flow cytometry analysis of guided tissue regeneration-associated human periodontal cells. J Periodontol 72 (2001) 1016-1024
45. Gerstenfeld L.C., Chipman S.D., Glowacki J., and Lian J.B. Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev Biol 122 (1987) 49-60
46. Chentoufi J., Hott M., Lamblin D., Buc-Caron M.H., Marie P.J., and Kellermann O. Kinetics of in vitro mineralization by an osteogenic clonal cell line (C1) derived from mouse teratocarcinoma. Differentiation 53 (1993) 181-189
47. Rosenzweig B.L., Imamura T., Okadome T., Cox G.N., Yamashita H., ten Dijke P., et al. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci U S A 92 (1995) 7632-7636
48. Rose-John S., and Heinrich P.C. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 300 (1994) 281-290
49. Muller-Newen G., Kohne C., and Heinrich P.C. Soluble receptors for cytokines and growth factors. Int Arch Allergy Immunol 111 (1996) 99-106
50. Muller-Newen G., Kohne C., Keul R., Hemmann U., Muller-Esterl W., Wijdenes J., et al. Purification and characterization of the soluble interleukin-6 receptor from human plasma and identification of an isoform generated through alternative splicing. Eur J Biochem 236 (1996) 837-842
51. Reiland J., Ott V.L., Lebakken C.S., Yeaman C., McCarthy J., and Rapraeger A.C. Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1. Biochem J 319 (1996) 39-47
52. Vecchi M., Baulida J., and Carpenter G. Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation. J Biol Chem 271 (1996) 18989-18995
53. Vecchi M., and Carpenter G. Constitutive proteolysis of the ErbB-4 receptor tyrosine kinase by a unique, sequential mechanism. J Cell Biol 139 (1997) 995-1003
54. Izumi Y., Hirose T., Tamai Y., Hirai S., Nagashima Y., Fujimoto T., et al. An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of Caenorhabditis elegans polarity protein PAR-3. J Cell Biol 143 (1998) 95-106
55. Vecchi M., Rudolph-Owen L.A., Brown C.L., Dempsey P.J., and Carpenter G. Tyrosine phosphorylation and proteolysis. Pervanadate-induced, metalloprotease-dependent cleavage of the ErbB-4 receptor and amphiregulin. J Biol Chem 273 (1998) 20589-20595
56. Rizoli S.B., Rotstein O.D., and Kapus A. Cell volume-dependent regulation of L-selectin shedding in neutrophils. A role for p38 mitogen-activated protein kinase. J Biol Chem 274 (1999) 22072-22080
57. Umata T., Hirata M., Takahashi T., Ryu F., Shida S., Takahashi Y., et al. A dual signaling cascade that regulates the ectodomain shedding of heparin-binding epidermal growth factor-like growth factor. J Biol Chem 276 (2001) 30475-30482
58. Miyazono K. Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone 25 (1999) 91-93
59. Kang Y.M., Yeh Y.L., and Graves D.T. Interleukin-1 modulates phosphorylation of proteins in human osteoblastic cells. J Bone Miner Res 10 (1995) 96-105
60. Ebara S., and Nakayama K. Mechanism for the action of bone morphogenetic proteins and regulation of their activity. Spine 27 (2002) S10-S15
61. van der H.G., van Bezooijen R.L., Deckers M.M., Hoogendam J., Visser A., Lowik C.W., et al. Differentiation of murine preosteoblastic KS483 cells depends on autocrine bone morphogenetic protein signaling during all phases of osteoblast formation. Bone 31 (2002) 661-669
62. Noth U., Tuli R., Seghatoleslami R., Howard M., Shah A., Hall D.J., et al. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res 291 (2003) 201-211